(142 days)
Not Found
No
The 510(k) summary describes a mechanical knee implant system and does not mention any software, algorithms, or AI/ML capabilities.
Yes
The device is a total knee system intended to alleviate pain and restore function in patients with painful, disabling joint disease of the knee, which aligns with the definition of a therapeutic device.
No
The device description clearly states "components are intended for use in primary and revision total knee arthroplasty to alleviate pain and restore function". This device is an implantable medical device for joint replacement, not a diagnostic tool.
No
The device description clearly states it includes physical components like femoral components, tibial inserts, stem extenders, offset adapters, and stems, which are hardware.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "primary and revision total knee arthroplasty to alleviate pain and restore function." This describes a surgical procedure involving the implantation of a medical device.
- Device Description: The device description details components of a knee replacement system (femoral components, tibial inserts, stem extenders, etc.). These are physical implants used in surgery.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening.
IVD devices are used in vitro (outside the body) to analyze biological samples. This device is used in vivo (inside the body) as a surgical implant.
N/A
Intended Use / Indications for Use
The Triathlon TS Total Knee System components are intended for use in primary and revision total knee arthroplasty to alleviate pain and restore function. All total knee components presented in this submission are provided sterile for single-use.
General Total Knee Arthroplasty (TKR) Indications:
- Painful, disabling joint disease of the knee resulting from: noninflammatory . degenerative joint disease (including osteoarthritis, traumatic arthritis, or avascular necrosis), rheumatoid arthritis or post-traumatic arthritis.
- Post-traumatic loss of knee joint configuration and function.
- Moderate varus, valgus, or flexion deformity in which the ligamentous structures . can be returned to adequate function and stability.
- Revision of previous unsuccessful knee replacement or other procedure. .
- . Fracture of the distal femur and/or proximal tibia that cannot be stabilized by standard fracture management techniques.
Additional Indications for Posterior Stabilized (PS) and Total Stabilizer (TS) Components:
- . Ligamentous instability requiring implant bearing surface geometries with increased constraint.
- . Absent or non-functioning posterior cruciate ligament.
- Severe anteroposterior instability of the knee joint. .
Additional Indications for Total Stabilizer (TS) Components:
-
Severe instability of the knee secondary to compromised collateral ligament ● integrity or function.
Indications for Bone Augments: -
. Painful, disabling joint disease of the knee secondary to: degenerative arthritis. rheumatoid arthritis, or post-traumatic arthritis, complicated by the presence of bone loss.
-
Salvage of previous unsuccessful total knee replacement or other surgical . procedure, accompanied by bone loss.
-
Salvage of previous unsuccessful total knee replacement or other surgical . procedure, accompanied by bone loss.
The Triathlon TS Total Knee System components are intended for cemented use only.
Product codes (comma separated list FDA assigned to the subject device)
87 JWH
Device Description
A total stabilizing version of the Triathlon Total Knee System has been developed and will now include femoral components and tibial inserts compatible with the Triathlon universal tibial components cleared previously. The new Triathlon TS Knee is designed to accommodate patients with severely deficient bone stock who require additional components for increased stabilization. The Triathlon TS System will include femoral components, stem extenders, offset adapters, stems, and tibial inserts in standard and TS Plus design. Implants will be available in sizes 1 through 8. Product descriptions, product codes and engineering drawings are provided for review.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Knee
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K973164, K031729, K042993, K053514
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3560 Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis.
(a)
Identification. A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.
0
K070095 510(k) Summary of Safety and Effectiveness for the Triathlon® TS Knee System
JUN - 1 2007
| Proprietary Name: | Triathlon® TS Knee System |
|---|---|
| Common Name: | Total Knee Joint Replacement Prosthesis |
| Classification Name and Reference | Joint patellofemorotibial |
| polymer/metal/polymer semi-constrained | |
| cemented prosthesis. | |
| 21 CFR §888.3560 | |
| Regulatory Class: | Class II |
| Device Product Code: | 87 JWH - prosthesis, knee, |
| patellofemorotibial, semi-constrained, | |
| cemented, polymer/metal/polymer | |
| For Information contact: | Tiffani Rogers |
| Regulatory Affairs Specialist | |
| Stryker Orthopaedics | |
| 325 Corporate Drive | |
| Mahwah, New Jersey 07432 | |
| Phone: (201) 831-5412 | |
| Fax: (201) 831-6038 | |
| E-Mail: Tiffani.Rogers@stryker.com | |
| Date Summary Prepared: | June 1, 2007 |
Device Description
A total stabilizing version of the Triathlon Total Knee System has been developed and will now include femoral components and tibial inserts compatible with the Triathlon universal tibial components cleared previously. The new Triathlon TS Knee is designed to accommodate patients with severely deficient bone stock who require additional components for increased stabilization. The Triathlon TS System will include femoral components, stem extenders, offset adapters, stems, and tibial inserts in standard and TS Plus design. Implants will be available in sizes 1 through 8. Product descriptions, product codes and engineering drawings are provided for review.
1
Intended Use:
The Triathlon TS Total Knee System components are intended for use in primary and revision total knee arthroplasty to alleviate pain and restore function. All total knee components presented in this submission are provided sterile for single-use.
Indications for Use
General Total Knee Arthroplasty (TKR) Indications:
- Painful, disabling joint disease of the knee resulting from: noninflammatory . degenerative joint disease (including osteoarthritis, traumatic arthritis, or avascular necrosis), rheumatoid arthritis or post-traumatic arthritis.
- Post-traumatic loss of knee joint configuration and function.
- Moderate varus, valgus, or flexion deformity in which the ligamentous structures . can be returned to adequate function and stability.
- Revision of previous unsuccessful knee replacement or other procedure. .
- . Fracture of the distal femur and/or proximal tibia that cannot be stabilized by standard fracture management techniques.
Additional Indications for Posterior Stabilized (PS) and Total Stabilizer (TS) Components:
- . Ligamentous instability requiring implant bearing surface geometries with increased constraint.
- . Absent or non-functioning posterior cruciate ligament.
- Severe anteroposterior instability of the knee joint. .
Additional Indications for Total Stabilizer (TS) Components:
- Severe instability of the knee secondary to compromised collateral ligament ● integrity or function.
Indications for Bone Augments:
- . Painful, disabling joint disease of the knee secondary to: degenerative arthritis. rheumatoid arthritis, or post-traumatic arthritis, complicated by the presence of bone loss.
- Salvage of previous unsuccessful total knee replacement or other surgical . procedure, accompanied by bone loss.
- Salvage of previous unsuccessful total knee replacement or other surgical . procedure, accompanied by bone loss.
The Triathlon TS Total Knee System components are intended for cemented use only.
Substantial Equivalence:
The determination of the substantial equivalence of the Triathlon TS total knee system is based on similarities in intended use, design and sterilization to the Howmedica Total Stabilizing Total Knee System (K973164, cleared August 22, 1997), Triathlon PS Knee System (K031729, cleared September 2, 2003 and K042993 cleared January 12, 2005) and the Triathlon® Total Knee System (K053514, cleared January 26, 2006).
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes forming its wing. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN - 1 2007
JUN - 1 2007
Howmedica Osteonics Corp. c/o Ms. Tiffani D. Rogers Regulatory Affairs Specialist 325 Corporate Drive Mahwah, New Jersey 07430
Re: K070095
Trade/Device Name: Triathlon TS Knee System Regulation Number: 21 CFR 888.3560 Regulation Name: Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis Regulatory Class: Class II Product Code: JWH Dated: May 17, 2007 Received: May 18, 2007
Dear Ms. Rogers:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Ms. Tiffani D. Rogers
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Alvin M. McRaven
City Sign Off
090095
Division of General. Restorative, and Neurological Devices
510(k) Number
510(k) Number (if known):
Device Name: Triathlon® TS Knee System
Indications for Use
General Total Knee Arthroplasty (TKR) Indications:
- Painful, disabling joint disease of the knee resulting from: noninflammatory . degenerative joint disease (including osteoarthritis, traumatic arthritis, or avascular necrosis), rheumatoid arthritis or post-traumatic arthritis.
- . Post-traumatic loss of knee joint configuration and function.
- Moderate varus, valgus, or flexion deformity in which the ligamentous structures . can be returned to adequate function and stability.
- . Revision of previous unsuccessful knee replacement or other procedure.
- Fracture of the distal femur and/or proximal tibia that cannot be stabilized by . standard fracture management techniques.
Additional Indications for Posterior Stabilized (PS) and Total Stabilizer (TS) Components:
- Ligamentous instability requiring implant bearing surface geometries with . increased constraint.
- . Absent or non-functioning posterior cruciate ligament.
- . Severe anteroposterior instability of the knee joint.
Additional Indications for Total Stabilizer (TS) Components:
- Severe instability of the knee secondary to compromised collateral ligament . integrity or function.
Indications for Bone Augments:
- Painful, disabling joint disease of the knee secondary to: degenerative arthritis, . rheumatoid arthritis, or post-traumatic arthritis, complicated by the presence of bone loss.
- Salvage of previous unsuccessful total knee replacement or other surgical . procedure, accompanied by bone loss.
- . Salvage of previous unsuccessful total knee replacement or other surgical procedure, accompanied by bone loss.
The Triathlon TS Total Knee System components are intended for cemented use only.
x Over-the-Counter Use Prescription Use OR (Per 21 CFR 801.109)
(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)